chr17-18155224-C-T

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBS1BS2

The NM_016239.4(MYO15A):​c.8339C>T​(p.Thr2780Met) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.00148 in 1,613,956 control chromosomes in the GnomAD database, including 54 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. T2780T) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.0039 ( 20 hom., cov: 33)
Exomes 𝑓: 0.0012 ( 34 hom. )

Consequence

MYO15A
NM_016239.4 missense, splice_region

Scores

1
1
15
Splicing: ADA: 0.01123
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 4.40

Publications

2 publications found
Variant links:
Genes affected
MYO15A (HGNC:7594): (myosin XVA) This gene encodes an unconventional myosin. This protein differs from other myosins in that it has a long N-terminal extension preceding the conserved motor domain. Studies in mice suggest that this protein is necessary for actin organization in the hair cells of the cochlea. Mutations in this gene have been associated with profound, congenital, neurosensory, nonsyndromal deafness. This gene is located within the Smith-Magenis syndrome region on chromosome 17. Read-through transcripts containing an upstream gene and this gene have been identified, but they are not thought to encode a fusion protein. Several alternatively spliced transcript variants have been described, but their full length sequences have not been determined. [provided by RefSeq, Jul 2008]
MYO15A Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

PM1
In a hotspot region, there are 5 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 4 uncertain in NM_016239.4
BP4
Computational evidence support a benign effect (MetaRNN=0.00789547).
BP6
Variant 17-18155224-C-T is Benign according to our data. Variant chr17-18155224-C-T is described in ClinVar as Benign. ClinVar VariationId is 45768.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00389 (593/152316) while in subpopulation AMR AF = 0.0364 (557/15302). AF 95% confidence interval is 0.0339. There are 20 homozygotes in GnomAd4. There are 371 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 20 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYO15ANM_016239.4 linkc.8339C>T p.Thr2780Met missense_variant, splice_region_variant Exon 46 of 66 ENST00000647165.2 NP_057323.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYO15AENST00000647165.2 linkc.8339C>T p.Thr2780Met missense_variant, splice_region_variant Exon 46 of 66 NM_016239.4 ENSP00000495481.1

Frequencies

GnomAD3 genomes
AF:
0.00390
AC:
594
AN:
152198
Hom.:
20
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000362
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0365
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000132
Gnomad OTH
AF:
0.00526
GnomAD2 exomes
AF:
0.00519
AC:
1292
AN:
249162
AF XY:
0.00403
show subpopulations
Gnomad AFR exome
AF:
0.000518
Gnomad AMR exome
AF:
0.0363
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000556
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000796
Gnomad OTH exome
AF:
0.00215
GnomAD4 exome
AF:
0.00123
AC:
1795
AN:
1461640
Hom.:
34
Cov.:
34
AF XY:
0.00108
AC XY:
784
AN XY:
727136
show subpopulations
African (AFR)
AF:
0.000508
AC:
17
AN:
33474
American (AMR)
AF:
0.0358
AC:
1601
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000313
AC:
27
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53254
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000719
AC:
80
AN:
1111950
Other (OTH)
AF:
0.00113
AC:
68
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
141
281
422
562
703
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00389
AC:
593
AN:
152316
Hom.:
20
Cov.:
33
AF XY:
0.00498
AC XY:
371
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.000361
AC:
15
AN:
41574
American (AMR)
AF:
0.0364
AC:
557
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000132
AC:
9
AN:
68016
Other (OTH)
AF:
0.00520
AC:
11
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
28
56
83
111
139
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000595
Hom.:
0
Bravo
AF:
0.00609
ExAC
AF:
0.00336
AC:
407
EpiCase
AF:
0.000164
EpiControl
AF:
0.00

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Aug 04, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Thr2780Met in exon 46 of MYO15A: This variant is not expected to have clinical significance because it has been identified in 3.4% (391/11528) of Latino chrom osomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org ; dbSNP rs143826293).

Jan 30, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Autosomal recessive nonsyndromic hearing loss 3 Benign:2
Sep 01, 2021
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Oct 29, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign.

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.087
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.27
CADD
Benign
21
DANN
Benign
0.88
DEOGEN2
Benign
0.034
T;T;T;.;.
Eigen
Benign
-0.34
Eigen_PC
Benign
-0.22
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.78
T;.;T;T;T
MetaRNN
Benign
0.0079
T;T;T;T;T
MetaSVM
Benign
-0.70
T
MutationAssessor
Benign
0.0
.;L;L;.;.
PhyloP100
4.4
PrimateAI
Benign
0.41
T
PROVEAN
Benign
0.0
.;N;.;.;.
REVEL
Benign
0.0
Sift
Pathogenic
0.0
.;T;.;.;.
Sift4G
Benign
0.12
T;T;.;T;.
Vest4
0.15
ClinPred
0.019
T
GERP RS
3.3
Varity_R
0.023
gMVP
0.31
Mutation Taster
=86/14
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.011
dbscSNV1_RF
Benign
0.088
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143826293; hg19: chr17-18058538; API